WORLDWIDE CLINICAL-EXPERIENCE WITH CEFOPERAZONE

被引：22

作者：

GERBER, AU

CRAIG, WA

机构：

[1] WILLIAM S MIDDLETON MEM VET ADM HOSP,DEPT MED,MED SERV,MADISON,WI 53705

[2] UNIV WISCONSIN,DEPT MED,MADISON,WI 53706

来源：

关键词：

D O I：

10.2165/00003495-198100221-00022

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：108 / 118

页数：11

共 10 条

[1] BUNDTZEN RW, 1981, REV INFECT DIS, V3, P28
[2] CRAIG WA, 1980, CLIN THER, V3, P46
[3] PROTEIN-BINDING OF ANTIMICROBIALS - CLINICAL PHARMACOKINETIC AND THERAPEUTIC IMPLICATIONS
CRAIG, WA
WELLING, PG
[J]. CLINICAL PHARMACOKINETICS, 1977, 2 (04) : 252 - 268
[4] JONES RN, 1980, CURRENT CHEMOTHERAPY, V1, P179
[5] SUSCEPTIBILITIES OF ANAEROBIC-BACTERIA TO CEFOPERAZONE AND OTHER ANTIBIOTICS
KAYE, D
KOBASA, W
KAYE, K
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (06) : 957 - 960
[6] MASHIMO K, 1980, CLIN THER, V3, P159
[7] MATSUMOTO K, 1980, CURRENT CHEMOTHERAPY, V1, P169
[8] NISHIURA T, 1980, CLIN THER, V3, P190
[9] SHIBATA K, 1980, CLIN THER, V3, P173
[10] UEDA Y, 1980, CURRENT CHEMOTHERAPY, V1, P165